Skip to main content

Table 1 Demographic and clinical characterization of patients per group

From: Clinical characteristics of patients with suspected Alzheimer’s disease within a CSF Aß-ratio grey zone

Variable

Group

Test statistic and

p value

ES

Grey Zone

n = 63

low Aß1-42

n = 42

AD

n = 80

Demographics

Age at diagnosis (years), median (IQR)

71 (68–76)

72.4 (67–79)

72 (68–78)

H(2) = 0.450, p = 0.799

0.19

Sex (Female), n (%)

40 (63.49%)

19 (45.24%)

41 (51.25%)

X2(2) = 3.827, p = 0.148

0.14

Education (years), median (IQR)

16 (11–18)

14.5 (12–18)

13 (11–16)

H(2) = 2.519, p = 0.284

0.11

History of dementia in first degree relatives, n (%)

21 (33.3%)

21 (50%)

31 (38.75%)

X2(2) = 1.481, p = 0.477

0.10

Medical history, n (%)

Arterial hypertension

27 (42.9%)

22 (52.4%)

46 (58.2%)

X2(2) = 0.876, p = 0.645

0.08

Diabetes mellitus

10 (15.9%)

5 (11.9%)

7 (8.8%)

X2(2) = 3.025, p = 0.220

0.17

Dyslipidaemia

32 (50.8%)

22 (52.4%)

38 (47.5%)

X2(2) = 1.054, p = 0.591

0.09

OSAS

4 (6.4%)

4 (9.5%)

4 (5.0%)

X2(2) = 1.104, p = 0.576

0.10

Smoking

8 (12.7%)

6 (14.29%)

13 (16.25%)

X2(4) = 1.026, p = 0.906

0.10

Depression

13 (20.63%)

6 (14.28%)

18 (22.5%)

X2(2) = 0.646, p = 0.724

0.07

Ischemic stroke/TIA

2 (3.17%)

5 (11.9%)

6 (7.5%)

X2(4) = 3.307, p = 0.508

0.13

Coronary heart disease

4 (6.35%)

4 (9.52%)

6 (7.5%)

X2(2) = 0.359, p = 0.836

0.06

Clinical severity, n (%)

   

X2(8) = 46.459, p < 0.001

0.38

CDR total score 0

28 (44.4%)

14 (33.3%)

0 (0%)

  

CDR total score 0.5

17 (26.98%)

11 (26.19%)

20 (25%)

  

CDR total score ≥ 1

18 (28.57%)

17 (40.48%)

60 (75%)

  
  1. AD, Alzheimer’s disease, CDR, Clinical dementia rating scale, ES, effect sizes, IQR, Interquartile range, OSAS, obstructive sleep apnoea syndrome, TIA, transitory ischemic attack